Projects

Indian Multiple Sclerosis and Allied Demyelinating Disorders Registry and Research Network

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2027

Project Lead

Dr. Thomas Mathew

Authors

Dr. Thomas Mathew Dr. G.R.K Sarma Dr. Raghunandan Nadig

Project Status

ongoing

Project Type

ICMR